Effects of transcutaneous auricular vagus nerve stimulation in individuals with Parkinson's disease - a double-blind randomized controlled clinical trial
- Conditions
- Parkinson&aposs diseaseC10.228.140.079.862
- Registration Number
- RBR-6xtvg5w
- Lead Sponsor
- niversidade Federal de São Carlos
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Individuals of both sexes; aged between 40-80 years, with a diagnosis confirmed by a neurologist of Parkinson's disease present in stages 1 to 3 of the Hoehn and Yahr scale; who have motor and cognitive complaints related to the Unified Parkinson's Disease Rating Scale (UPDRS) and who have been on stable Parkinson Disease medication for at least 30 days
Individuals with characteristics of other types of parkinsonism; having other health conditions such as musculoskeletal problems, decompensated respiratory or cardiovascular problems, uncontrolled diabetes, uncontrolled systemic arterial hypertension, psychiatric conditions such as dementia diagnosed by a psychiatrist, contraindications for the intervention (implanted cardiac or cranial electronic medical devices, cochlear implant, pacemaker) or conditions in which the principal investigator assesses as not indicated for participation in the study
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the overall function of individuals with Parkinson's disease throught the Unified Parkinson Disease Rating Scale (UPDRS). The result will be assessed by comparing the score in the pre- and post-intervention evaluation. It is expected that there will be no significant difference in most of the items on the assessment tool, with the exception of the motor section
- Secondary Outcome Measures
Name Time Method